ongo
global
mortal
morbid
associ
viral
pathogen
highlight
need
continu
develop
effect
novel
antivir
molecul
antivir
activ
cation
host
defenc
peptid
signific
interest
novel
therapeut
treat
viral
infect
predominantli
due
broad
spectrum
antivir
activ
peptid
also
display
power
immunomodulatori
activ
key
mediat
inflamm
therefor
offer
signific
opportun
inform
develop
novel
therapeut
treat
viral
infect
either
directli
target
pathogen
enhanc
innat
immun
respons
chapter
review
antivir
activ
cathelicidin
defensin
examin
potenti
peptid
use
novel
antivir
agent
ongo
mortal
diseas
associ
circul
viral
infect
human
anim
togeth
ongo
threat
emerg
viral
strain
underscor
requir
develop
novel
antivir
molecul
vaccin
common
viral
pathogen
effect
desir
direct
antivir
therapeut
play
key
role
treat
diseas
caus
viral
pathogen
vaccin
lack
global
vaccin
programm
vaccin
limit
efficaci
addit
resist
viral
pathogen
common
antivir
drug
increas
new
class
antivir
molecul
could
provid
strategi
treatment
exist
emerg
infect
decad
come
antivir
activ
cation
host
defenc
peptid
chdp
also
known
antimicrobi
peptid
increas
interest
inform
develop
novel
antivir
therapeut
due
broad
spectrum
activ
chdp
play
key
role
innat
immun
respons
bacteri
viral
pathogen
addit
chdp
substanti
immunomodulatori
activ
contribut
rapid
clearanc
infect
therefor
better
understand
antivir
immunomodulatori
activ
chdp
context
viral
infect
great
import
race
develop
new
treatment
broadli
effect
viral
pathogen
chdp
small
evolutionarili
conserv
peptid
posit
charg
broad
spectrum
activ
rang
pathogen
vitro
vivo
human
two
major
famili
chdp
cathelicidin
defensin
howev
famili
exist
mammal
bird
fish
reptil
arthropod
plant
show
antimicrobi
potenti
antivir
activ
mani
peptid
establish
signific
number
studi
comprehens
understand
mechan
action
involv
remain
elus
particular
interest
immunomodulatori
inflammomodulatori
activ
chdp
gain
fundament
understand
innat
respons
infect
addit
inform
develop
novel
therapeut
chdp
shown
capac
modul
cell
death
pathway
infect
cell
assist
recruit
immun
cell
site
infect
promot
angiogenesi
alter
immun
cell
differenti
mediat
product
proand
antiinflammatori
cytokin
chapter
review
antivir
activ
cathelicidin
defensin
also
highlight
key
chdp
speci
demonstr
antivir
potenti
either
direct
antivir
activ
modul
immun
respons
infect
cathelicidin
rang
amino
acid
length
characteris
presenc
ntermin
signal
sequenc
direct
newli
synthesis
protein
toward
secretori
pathway
conserv
cathelinlik
domain
high
sequenc
homolog
porcin
cystein
proteas
inhibitor
cathelin
variabl
ctermin
antimicrobi
domain
becom
matur
function
peptid
upon
proteolyt
cleavag
cathelicidin
first
identifi
bovin
neutrophil
wide
distribut
mammal
includ
human
rhesu
monkey
rat
mice
guinea
pig
rabbit
sheep
cow
hors
dog
also
nonmammalian
speci
includ
chicken
rainbow
trout
hagfish
zanetti
et
al
human
one
cathelicidin
describedth
cation
antimicrobi
peptid
found
high
concentr
specif
granul
neutrophil
express
epitheli
cell
skin
mucosa
respiratori
urogenit
gastrointestin
tract
de
et
al
cleav
extracellularli
gener
activ
form
linear
aminoacid
peptid
two
leucin
residu
ntermin
amphipath
structur
sorensen
et
al
peptid
known
express
macrophag
eosinophil
lymphocyt
mast
cell
nk
tand
bcell
agerberth
et
al
mice
express
cathelicidin
mcramp
murin
cathelinrel
antimicrobi
peptid
high
sequenc
ident
porcin
cathelicidin
mcramp
show
similar
express
function
pattern
human
ortholog
gallo
et
al
store
neutrophil
granul
express
epitheli
cell
leukocyt
mcramp
knockout
mice
high
suscept
infect
compar
wild
type
mice
huang
et
al
iimura
et
al
kovach
et
al
contrast
human
mice
express
one
cathelicidin
pig
express
varieti
cathelicidin
differ
activ
structur
porcin
cathelicidin
includ
five
differ
protegrin
pg
three
peptid
two
prophenin
peptid
pg
produc
store
porcin
neutrophil
inact
propeptid
proteolyt
cleav
activ
form
neutrophil
elastas
extracellular
environ
express
enhanc
bacteri
lp
retino
acid
salmonella
infect
wu
et
al
shown
broadest
antimicrobi
activ
spectrum
yasin
et
al
b
cathelicidin
also
character
mani
speci
sheep
monkey
hors
cow
sheep
eight
cathelinassoci
peptid
identifi
sheep
myeloid
antimicrobi
peptid
one
potent
cation
host
defenc
peptid
known
term
antimicrobi
activ
wide
spectrum
activ
bacteria
fungi
viru
tomasinsig
zanetti
cathelicidin
play
key
role
host
defenc
via
direct
antimicrobi
activ
putsep
et
al
act
critic
immunomodulatori
molecul
control
inflamm
recent
number
studi
conduct
human
mice
vitro
model
highlight
potent
antivir
activ
cathelicidin
virus
suscept
cathelicidin
includ
envelop
dna
rna
virus
antivir
mechan
remain
elucid
appear
direct
effect
viral
envelop
howev
nonenvelop
virus
adenoviru
also
inactiv
cathelicidin
gordon
et
al
barlow
et
al
therefor
antivir
activ
peptid
like
compris
complex
array
mechan
explain
direct
effect
viru
particl
influenza
viru
iav
envelop
viru
orthomyxovirida
famili
viral
influenza
caus
death
peopl
short
period
time
infecti
diseas
taubenberg
moren
wellestablish
global
vaccin
programm
place
prevent
influenza
infect
annual
basi
limit
protect
preval
circul
strain
therefor
emerg
new
strain
potenti
lead
global
pandem
outbreak
antivir
treatment
avail
although
emerg
resist
circul
strain
neurominidas
inhibitor
one
current
frontlin
treatment
seriou
concern
nitschosuch
brydak
hurt
studi
demonstr
antivir
potenti
sever
cathelicidin
influenza
viru
studi
barlow
et
al
demonstr
antivir
properti
human
murin
cathelicidin
vivo
vitro
barlow
et
al
mcramp
porcin
cathelicidin
show
antivir
properti
preincub
iav
vitro
tripathi
et
al
demonstr
preincub
peptid
iav
necessari
optim
inhibit
iav
although
host
cell
pretreat
delay
treatment
exogen
also
inhibit
iav
replic
extent
tripathi
et
al
reveal
peptid
abil
interact
epitheli
cell
although
potent
activ
peptid
involv
direct
interact
viru
particl
vivo
studi
murin
model
receiv
mcramp
treatment
show
signific
increas
surviv
compar
salin
treat
mice
mice
treat
show
signific
alter
compar
control
group
barlow
et
al
demonstr
antivir
activ
cathelicidin
speciesspecif
propos
protect
iav
infect
modul
inflammatori
respons
lung
mice
infect
iav
exhibit
pronounc
upregul
numer
proinflammatori
cytokin
although
attenu
mice
suggest
modul
inflammatori
respons
inhibit
excess
inflamm
barlow
et
al
order
determin
effect
cellular
uptak
replic
iav
qpcr
use
quantifi
viral
infect
replic
result
show
reduc
number
viru
particl
associ
cell
min
infect
although
h
postinfect
caus
signific
reduct
amount
viru
present
cell
cell
cultur
supernat
tripathi
et
al
electron
microscop
imag
reveal
induc
disrupt
viral
membran
may
one
possibl
mechan
antivir
activ
interestingli
pandem
iav
strain
shown
resist
innat
inhibitor
season
iav
strain
human
murin
cathelicidin
recent
studi
compar
antivir
activ
deriv
fragment
season
pandem
strain
influenza
viru
reveal
central
fragment
show
greater
activ
pandem
iav
strain
vitro
tripathi
et
al
find
suggest
possibl
synthet
deriv
potent
antivir
activ
could
use
potenti
therapeut
infect
hiv
envelop
lentiviru
famili
retrovirida
caus
hiv
infect
acquir
immun
defici
syndrom
aid
estim
million
peopl
worldwid
live
hiv
around
million
new
infect
million
death
detect
piot
quinn
hallmark
infect
gradual
loss
tcell
lead
acquir
immun
defici
syndrom
aid
simon
et
al
product
viral
particl
per
day
togeth
low
fidel
revers
transcript
recombin
gener
viral
quasispeci
chronic
infect
subject
make
lifelong
treatment
combin
highli
activ
antiretrovir
drug
haart
option
capabl
keep
infect
control
indolicidin
cathelicidin
isol
larg
granul
bovin
neutrophil
first
show
antihiv
activ
robinson
et
al
thought
potent
antimicrobi
properti
indolicidin
relat
abil
disrupt
pathogen
membran
experiment
indolicidin
directli
inactiv
viru
particl
observ
attribut
membranemedi
antivir
mechan
vitro
studi
bergman
et
al
show
could
inhibit
replic
peripher
blood
mononuclear
cell
pbmc
includ
primari
tcell
shown
independ
formyl
peptid
signal
receptor
thought
partial
respons
mediat
chemotact
immunomodulatori
effect
bergman
et
al
barlow
et
al
anoth
studi
examin
antihiv
effect
deriv
fragment
togeth
fragment
deriv
bovin
cathelicidin
vitro
peptid
sequenc
order
aromat
residu
helic
structur
examin
shown
play
import
role
hiv
inhibit
central
fragment
known
activ
compar
studi
essenti
provid
new
antimicrobi
templat
could
use
develop
novel
antihiv
therapi
recent
studi
examin
effect
deriv
fragment
revers
transcriptas
integras
proteas
wong
et
al
shown
peptid
test
lack
abil
inhibit
transloc
integras
enzym
essenti
hiv
replic
potent
inhibitori
effect
peptid
seen
revers
transcriptas
central
peptid
reveal
strongest
inhibitori
activ
shown
strongli
express
epithelium
epididymi
suggest
import
role
antimicrobi
protect
reproduct
male
system
malm
et
al
also
shown
vagin
fluid
healthi
women
intrins
properti
confer
cation
polypeptid
deplet
cation
polypeptid
caus
reduct
intrins
activ
venkataraman
et
al
addit
cervicovagin
secret
cv
kenyan
women
hivserodiscord
relationship
contain
hiv
neutral
activ
cv
reveal
intrins
antihiv
activ
could
enhanc
addit
recombin
levinson
et
al
studi
reveal
high
concentr
found
cervicovagin
secret
cv
collect
kenyan
sex
worker
bacteri
transmit
infect
associ
increas
hiv
acquisit
levinson
et
al
find
seem
correl
previou
studi
cv
contain
hiv
neutral
activ
confer
cation
polypeptid
therefor
press
need
determin
vivo
signific
peptid
hiv
infect
junin
viru
jv
envelop
viru
arenavirida
famili
caus
argentin
haemorrhag
fever
ahf
studi
albiol
matan
castilla
assess
antivir
effect
indolicidin
junin
viru
although
determin
cathelicidin
abl
induc
substanti
rate
viral
inactiv
albiol
matan
castilla
howev
rel
low
virucid
action
indolicidin
junin
viru
observ
thought
due
direct
inactiv
viru
particl
similar
antivir
mechan
propos
action
cathelicidin
robinson
et
al
dengu
viru
denv
envelop
member
flavivirida
famili
caus
dengu
fevera
mosquitoborn
tropic
diseas
import
target
antivir
therapi
dengu
viru
serin
proteas
disrupt
serin
proteas
function
inhibit
viru
replic
studi
tambunan
alamudi
demonstr
cation
cyclic
peptid
high
potenti
inhibit
serin
proteas
activ
dengu
viru
tambunan
alamudi
recent
studi
propos
cation
cyclic
peptid
origin
isol
porcin
blood
cell
abl
inhibit
serin
proteas
activ
thu
translat
reduc
viral
replic
vitro
rothan
et
al
rsv
envelop
viru
member
paramyxovirida
famili
shown
respons
signific
number
respiratori
tract
infect
major
caus
viral
bronchiol
young
children
nair
et
al
recent
studi
demonstr
human
cathelicidin
display
concentrationdepend
antivir
activ
rsv
vitro
physiolog
relev
concentr
curri
et
al
inhibit
rsv
replic
decreas
spread
infect
effect
highest
peptid
preincub
rsv
ad
cell
simultan
studi
demonstr
mediat
direct
effect
viru
particl
similar
action
influenza
viru
tripathi
et
al
also
demonstr
delay
exposur
take
place
h
infect
result
loss
antivir
effect
reveal
inabl
peptid
rescu
infect
cell
howev
pretreat
cell
prior
infect
result
reduct
infect
suggest
peptid
retain
epitheli
cell
exert
protect
antivir
state
result
indic
protect
epitheli
cell
viral
infect
mechan
distinct
direct
antivir
activ
addit
also
shown
activ
protect
rsvinfect
epitheli
cell
cell
death
vaccinia
viru
vv
envelop
poxviru
famili
poxvirida
activ
constitu
vaccin
erad
smallpox
demonstr
individu
atop
dermat
ad
predisposit
develop
eczema
vaccinatum
respons
vaccin
individu
express
reduc
howel
et
al
shown
normal
skin
biopsi
express
induc
vaccinia
viru
observ
ad
skin
furthermor
studi
howel
et
al
demonstr
murin
cathelicidin
mcramp
antivir
activ
vaccinia
viru
antivir
mechan
exert
effect
involv
remov
outer
membran
vaccinia
viru
thu
caus
envelop
damag
howel
et
al
dean
et
al
herp
simplex
viru
envelop
virus
famili
herpesvirida
wide
found
human
particularli
infecti
suppress
antivir
drug
normal
suscept
complet
erad
host
studi
yasin
et
al
screen
host
defenc
peptid
test
antivir
activ
hsv
type
yasin
et
al
shown
littl
capac
induc
viral
inactiv
howev
bovin
cathelicidin
indolicidin
display
potent
antivir
activ
hsv
type
peptid
investig
antihsv
activ
includ
acronym
bovin
myeloid
antimicrobi
peptid
cathelicidin
found
bovin
neutrophil
synthet
fragment
analys
vitro
antivir
activ
shown
provid
protect
vitro
wherea
peptid
ineffect
noncytotox
concentr
benincasa
et
al
anoth
studi
examin
underli
mechan
potent
antivir
activ
indocilidin
observ
hsv
type
vitro
suggest
mechan
underlin
antivir
activ
relat
abil
peptid
disrupt
viral
envelop
thu
inactiv
viru
particl
albiol
matan
castilla
howev
contrari
previou
report
gordon
et
al
report
potent
antivir
activ
vitro
gordon
et
al
known
subgroup
patient
atop
dermat
ad
develop
eczema
herpeticum
adeh
due
dissemin
infect
hsv
wollenberg
et
al
patient
ad
decreas
express
host
defenc
peptid
suggest
defici
may
caus
patient
ad
suscept
adeh
ong
et
al
studi
howel
et
al
show
exhibit
direct
antivir
activ
vitro
addit
particularli
physiolog
relev
model
employ
wherebi
human
keratinocyt
cell
preincub
hsv
period
h
treatment
h
assess
whether
intracellular
viral
replic
could
inhibit
physiolog
concentr
howel
et
al
studi
show
peptid
abl
significantli
reduc
level
hsv
gene
express
infect
keratinocyt
vivo
studi
use
mice
defici
mcramp
reveal
higher
rate
hsv
replic
compar
wild
type
mice
indic
import
role
host
defenc
peptid
control
hsv
skin
infect
interestingli
recent
studi
test
compar
two
differ
approach
fight
corneal
infect
sustain
releas
deliv
nanoparticl
incorpor
within
corneal
implant
compar
cellbas
deliveri
cdna
transfect
hcec
human
corneal
epitheli
cell
releas
implant
show
abil
inhibit
activ
clear
infect
cell
hcec
produc
also
show
direct
activ
although
none
approach
abl
complet
elimin
viru
infect
lee
et
al
adenoviru
nonenvelop
viru
part
adenovirida
famili
adenovirus
major
caus
conjunct
keratoconjunct
also
caus
upper
lower
respiratori
gut
infect
although
usual
selflimit
human
adenoviru
hadv
infect
quit
contagi
put
immunocompromis
individu
seriou
risk
sever
recurr
pulmonari
infect
mortal
rate
reach
lion
treatment
infect
larg
support
therapi
rather
direct
antivir
therapeut
studi
gordon
et
al
investig
antivir
activ
differ
adenoviru
serotyp
gordon
et
al
demonstr
signific
reduct
titer
vitro
log
rothan
et
al
b
reduct
h
studi
also
provid
insight
potenti
antivir
mechan
cathelicidin
base
comparison
hsv
timekil
assay
data
demonstr
rapid
kill
suggest
disrupt
viral
lipid
membran
possibl
mechan
sever
studi
also
propos
similar
mechan
cathelicidin
robinson
et
al
albiol
matan
castilla
dean
et
al
interestingli
strain
produc
much
slower
progress
reduct
viru
titer
adenoviru
lack
viral
envelop
suggest
direct
antivir
mechan
cathelicidin
involv
membran
disrupt
altern
mechan
propos
disrupt
adenoviru
particl
detergenteffect
andor
blockag
viral
entri
cell
summari
review
current
literatur
show
cathelicidin
antivir
properti
broad
spectrum
virus
underli
mechan
like
involv
direct
effect
viral
particl
well
capac
modul
host
immun
respons
may
contribut
clearanc
infect
better
understand
cathelicidin
interact
viru
particl
directli
addit
effect
infect
host
cell
remain
establish
howev
clear
cathelicidin
ideal
target
compon
innat
immun
system
use
inform
develop
novel
therapeut
broad
activ
target
number
virus
tabl
defensin
small
cysteinerich
cation
peptid
act
import
effector
innat
immun
system
ding
et
al
ganz
human
defensin
classifi
accord
structur
differ
disulphid
bond
pair
present
old
world
monkey
display
circular
structur
lehrer
note
despit
rna
transcript
found
human
bone
marrow
cell
prematur
stop
codon
prevent
protein
translat
nguyen
et
al
neutrophil
hnp
mainli
synthes
prepropeptid
promyelocyt
bone
marrow
matur
peptid
store
granul
neutrophil
peptid
found
lower
concentr
nkcell
bcell
tcell
monocyt
macrophag
immatur
dendrit
cell
rehaum
hancock
contrast
human
alpha
defensin
constitut
express
secret
propeptid
paneth
cell
salivari
gland
also
genit
mucosa
ouellett
human
defensin
hbd
mainli
express
epitheli
cell
also
found
immun
cell
mainli
monocytemacrophag
dendrit
cell
wherea
found
rhesu
macaqu
leukocyt
ganz
tang
et
al
retrocyclin
artifici
peptid
base
human
defensin
pseudogen
also
shown
possess
antimicrobi
capac
tran
et
al
yasin
et
al
defensin
broad
antimicrobi
activ
includ
capac
inhibit
viral
infect
despit
structur
physic
similar
overal
size
posit
charg
defensin
variabl
antivir
activ
differ
activ
like
due
mechan
action
exhibit
peptid
toward
particular
dna
rna
viru
one
first
virus
shown
inhibit
inactiv
incub
effect
abrog
serum
addit
daher
et
al
work
shown
one
defensin
six
inhibit
infect
hazrati
et
al
interestingli
interact
viral
glycoprotein
present
viral
envelop
bound
heparan
sulfat
heparin
cellular
receptor
use
gain
entri
cell
interact
shown
result
diminish
viral
entri
contrast
studi
demonstr
lack
effect
bind
neither
heparan
sulfat
similar
antivir
effect
hsv
display
defensin
rhesu
defensin
retrocyclin
demonstr
inhibit
hsv
viral
entri
cell
yasin
et
al
peptid
retrocyclin
shown
interact
viral
glycoprotein
thu
interf
viral
entri
without
caus
signific
cytotox
target
cell
defensin
often
display
antivir
activ
span
differ
step
target
viru
cycl
regard
abl
block
hsv
viral
gene
express
even
ad
viru
infect
indic
defensin
also
abl
block
postentri
event
hsv
cycl
shown
exhibit
antivir
activ
hpv
primari
caus
cervic
cancer
sexual
transmit
infect
buck
et
al
block
hpv
infect
impair
virion
escap
endocyt
vesicl
recent
studi
also
suggest
block
viral
entri
interact
viral
particl
block
cleavag
necessari
step
success
viral
entri
postentri
event
wien
smith
detail
studi
hpv
interact
suggest
hydrophob
residu
particular
import
antivir
activ
hpv
nonenvelop
virus
gounder
et
al
teng
et
al
sever
defensin
shown
vari
potenti
neutral
vv
infect
incub
vv
h
shown
reduc
number
viral
plaqu
form
green
monkey
kidney
cell
addit
reduc
express
viral
dnadepend
rna
polymeras
howel
et
al
viral
infect
howev
show
activ
envelop
viru
howel
et
al
jc
polyomaviru
also
known
john
cunningham
viru
member
famili
polyovirida
chronic
infect
human
popul
pathogen
tend
caus
clinic
symptom
immunocompromis
individu
infect
spread
central
nervou
system
shackelton
et
al
wollebo
et
al
experiment
studi
panel
test
capac
neutral
jcpyv
infect
result
abl
block
infect
incub
viru
h
infect
svga
human
foetal
glial
cell
zin
et
al
interestingli
show
signific
cytotox
cell
concentr
wherea
neutral
jcpyv
dosedepend
manner
zin
et
al
dugan
et
al
note
show
anti
jcpyv
activ
experi
also
show
abl
interact
jcpyvvirion
stabil
viral
capsid
thu
prevent
viral
genom
releas
zin
et
al
novel
mechan
action
peptid
gener
thought
employ
detergentlik
mode
antivir
activ
bk
viru
share
genom
jcpyv
first
isol
urin
renal
transplant
individu
gardner
et
al
around
healthi
individu
england
shown
display
antibodi
viru
gener
absenc
symptom
gardner
symptom
note
consist
fever
nonspecif
upper
respiratori
infect
might
lead
kidney
manifest
cystiti
nephriti
immunocompromis
individu
receiv
transplant
reploeg
et
al
shown
reduc
viral
vprotein
express
vero
cell
incub
directli
viru
h
effect
contrast
show
inhibitori
effect
dugan
et
al
direct
antivir
effect
defensin
studi
shown
interact
directli
bk
viru
particl
induc
aggreg
thu
reduc
viral
attach
cell
membran
note
similar
antivir
effect
also
observ
relat
polyomavirus
simian
also
shown
also
abl
block
adenoviru
escap
endosom
shown
express
eukaryot
cell
line
show
potenti
protect
cell
adenovir
infect
particular
gropp
et
al
differ
hadv
speci
show
variabl
suscept
defensin
action
regard
inhibit
hadv
b
c
infect
increas
hadv
e
f
infect
show
similar
action
block
hadv
b
c
e
increas
f
infect
interestingli
similar
nonenvelop
virus
interact
adenovir
capsid
prevent
viral
uncoat
avoid
releas
endocyt
vesicl
nguyen
et
al
smith
et
al
smith
nemerow
studi
confirm
residu
critic
antivir
effect
seen
adenoviru
gounder
et
al
much
less
known
defensin
effect
adenoviru
howev
shown
effect
concentr
block
adenovirustyp
infect
cell
wherea
show
reduc
effect
bastian
cmv
envelop
viru
belong
herpesvirida
famili
common
congenit
infect
affect
live
birth
huygen
et
al
foetal
perinat
infect
devast
neurolog
consequ
babi
howev
postnat
cmv
infect
usual
asymptomat
establish
lifelong
infect
without
sever
consequ
immun
compet
individu
context
chdp
activ
viru
super
physiolog
concentr
peptid
shown
directli
inhibit
cmv
viral
particl
reduc
pfuml
log
respect
daher
et
al
howev
viru
notabl
show
less
suscept
compar
also
assess
studi
baculoviru
natur
infect
insect
larva
host
usual
lepidoptera
butterfli
moth
known
diseas
caus
viru
organ
other
arthropod
airenn
et
al
due
effici
reproduct
cycl
abil
carri
larg
dna
insert
baculoviru
extens
use
tool
gene
deliveri
recombin
product
protein
insect
cell
baculoviru
protein
allow
viral
fusion
acidifi
endosom
event
seen
upon
infect
spodoptera
frugiperda
insect
cell
result
express
format
cell
syncytia
leikina
et
al
howev
shown
peptid
capabl
block
baculoviru
fusion
host
cell
inhibit
virusmedi
syncytium
format
shown
varieti
defensin
peptid
impact
hiv
infect
clearli
deleteri
viral
dissemin
direct
effect
low
multipl
infect
moi
viral
particl
absenc
serum
wherea
presenc
serum
act
host
cell
chang
et
al
one
suggest
mechan
cellular
effect
mediat
inhibit
pkc
signal
pathway
requir
viral
uncoat
field
et
al
importantli
effect
affect
express
viral
receptor
chang
et
al
interestingli
part
direct
effect
hiv
viral
particl
peptid
shown
interact
viral
glycoprotein
thu
impair
viral
attach
cell
membran
effect
potenti
interact
cellular
antivir
effect
reduc
complet
abolish
presenc
serum
demirkhanyan
et
al
furci
et
al
wang
et
al
close
relat
peptid
also
abl
bind
wu
et
al
indirect
also
effect
antihiv
effect
peptid
capac
increas
secret
cc
chemokin
rant
bind
act
antagonist
viral
strain
use
coreceptor
guo
et
al
stark
contrast
seem
increas
viral
infect
without
blockag
postentri
viral
event
klotman
et
al
assess
unexpect
effect
suggest
actual
enhanc
viral
attach
cell
rapista
et
al
anoth
studi
howev
show
inhibit
hiv
infect
block
interact
furci
et
al
work
need
clarifi
effect
hiv
infect
process
particularli
consid
sexual
transmit
infect
may
increas
secret
genit
mucosa
prior
possibl
hiv
infect
klotman
et
al
given
import
hiv
interact
mucos
surfac
impact
hiv
infect
also
investig
hiv
shown
upregul
releas
human
oral
epitheli
cell
incub
viral
particl
peptid
protect
cell
infect
et
al
interestingli
neither
upregul
protect
context
howev
appear
act
directli
viral
particl
also
host
cell
downregul
express
accordingli
peptid
found
effect
viral
isol
later
studi
found
similar
antihiv
activ
strain
indic
defensin
treatment
inhibit
earli
product
revers
transcript
sun
et
al
given
interest
broad
antivir
effect
defensin
rhesu
macaqu
rtd
synthet
retrocyclin
rc
also
test
antihiv
activ
shown
bind
glycosyl
thu
explain
previous
observ
protect
activ
cole
et
al
wang
et
al
interestingli
rtd
peptid
also
show
antihiv
activ
wang
et
al
work
demonstr
abl
block
fusion
target
cell
final
rhesu
macaqu
rmad
also
show
antihiv
activ
block
viral
entri
tanab
et
al
interestingli
studi
show
mous
deriv
actual
increas
replic
regard
guinea
pig
rabbit
rat
also
test
antihiv
activ
demonstr
abil
inhibit
infect
tcell
line
nakashima
et
al
hepat
c
infect
primarili
affect
liver
major
caus
chronic
hepat
cirrhosi
hepatocellular
carcinoma
maheshwari
et
al
hcv
infect
estim
affect
million
peopl
worldwid
frequent
asymptomat
spontan
clearanc
seen
third
infect
individu
chronic
infect
viral
replic
detect
month
lead
hepat
complic
littl
known
capac
defensin
impact
viral
hepat
howev
shown
hcv
core
protein
shown
activ
transcript
alphadefensin
gene
indic
may
play
role
innat
immun
respons
viru
aceti
et
al
earli
studi
report
activ
awsn
strain
iav
daher
et
al
detail
work
shown
affect
influenza
replic
block
pkc
signal
pathway
host
cell
need
viral
endosom
traffick
salvator
et
al
shown
direct
impact
viral
particl
increas
viral
clearanc
neutrophil
tecl
et
al
similar
effect
also
observ
lesser
extent
anoth
also
shown
block
iav
infect
block
hemagglutininmedi
fusion
immobil
membran
protein
leikina
et
al
interestingli
also
show
similar
effect
note
murin
protect
mice
infect
iav
strain
similar
human
analogu
activ
attribut
impair
viral
entri
gong
et
al
jiang
et
al
defensin
express
high
concentr
inflam
lung
usual
upregul
viral
infect
airway
epithelia
context
demonstr
rsv
infect
increas
secret
alveolar
cell
subsequ
abl
block
viral
entri
directli
disrupt
viral
envelop
kota
et
al
interestingli
rsv
induc
express
constitut
lack
direct
antirsv
activ
although
alveolar
macrophag
permiss
rsv
infect
tend
influenc
later
develop
diseas
pribul
et
al
howev
interact
result
increas
secret
proinflammatori
cytokin
impact
express
lung
becker
et
al
rhinoviru
major
caus
common
cold
associ
asthma
exacerb
jartti
korppi
demonstr
infect
primari
bronchial
epitheli
cell
result
induct
mrna
wherea
remain
unalt
duit
et
al
also
demonstr
serotyp
also
upregul
mrna
protein
alveolar
epitheli
cell
interestingli
effect
conserv
major
group
serotyp
minor
group
serotyp
work
investig
inocul
human
subject
divid
nonsmok
smoker
copd
group
proud
et
al
interestingli
larger
proport
smoker
success
inocul
viru
compar
copd
nonsmok
shown
increas
secret
sputum
day
postinfect
compar
baselin
observ
copd
group
mallia
et
al
infect
also
result
increas
neutrophil
elastas
may
subsequ
degrad
secret
host
defenc
peptid
enter
cytopath
human
orphan
echo
viru
belong
picornavirida
famili
enterovirus
mainli
found
gastrointestin
tract
caus
opportunist
infect
mainli
children
indirect
faecalor
transmiss
caus
febril
ill
sherri
medic
microbiolog
peptid
test
antivir
activ
nonenvelop
rna
viru
without
show
direct
antivir
effect
concentr
peptid
known
inhibit
daher
et
al
similar
echoviru
show
direct
activ
dsrna
nonenvelop
viru
gener
caus
mild
limit
upper
respiratori
gastrointestin
tract
infect
spread
across
individu
also
across
speci
daher
et
al
interestingli
use
reoviru
contempl
cancer
therapi
due
oncolyt
activ
melanoma
line
xenograft
galani
et
al
vsiv
belong
rhabdovirida
famili
arthropodborn
viru
primarili
affect
rodent
cattl
swine
hors
infect
livestock
sand
fli
sourc
infect
human
develop
mild
flulik
symptom
kuzmin
et
al
envelop
rna
viru
show
intermedi
suscept
direct
inactiv
peptid
reduc
pfuml
log
peptid
respect
daher
et
al
sever
acut
respiratori
syndrom
sar
affect
individu
caus
almost
death
underscor
import
test
antivir
agent
peiri
et
al
shown
intranas
inject
peptid
prior
viru
inocul
protect
balbc
mice
mouseadapt
strain
sarscov
wohlfordlenan
et
al
note
untreat
anim
exhibit
around
mortal
rate
wherea
treat
one
show
surviv
treatment
alter
lung
cytokin
respons
viru
suggest
immunomodulatori
effect
least
part
behind
protect
action
interestingli
gene
code
upregul
blood
sampl
patient
suffer
acut
sar
coronaviru
infect
lee
et
al
recombin
peptid
shown
reduc
viral
replic
vero
cell
incub
directli
viral
particl
also
show
moder
effect
pretreat
treat
cell
postvir
entri
rothan
et
al
studi
suggest
impact
replic
inhibit
activ
viral
serin
proteas
interestingli
studi
show
human
skin
fibroblast
releas
upon
infect
bustosarriaga
et
al
sinv
member
togavirida
famili
transmit
mosquito
vector
caus
sindbi
fever
result
arthralgia
malais
rash
shown
peptid
abl
block
viru
fusion
target
cell
leikina
et
al
tabl
addit
wellcharacter
activ
cathelicidin
defensin
wide
varieti
viral
pathogen
number
chdp
nonhuman
organ
focu
number
studi
attempt
understand
whether
peptid
synthet
deriv
could
use
inform
design
novel
therapeut
viral
infect
specif
human
substanti
divers
chdp
exist
across
number
speci
possess
activ
human
pathogen
antimicrobi
peptid
databas
http
apsunmceduap
contain
excess
peptid
demonstr
antimicrobi
activ
isol
six
kingdom
includ
peptid
bacteria
fungi
plant
amphibian
fish
reptil
bird
interestingli
approxim
peptid
includ
cathelicidin
defensin
demonstr
antivir
activ
broad
rang
viral
pathogen
famili
chdp
particularli
potent
activ
human
viral
pathogen
cecropin
peptid
identifi
initi
cecropia
moth
hyalophoracecropia
form
part
immun
respons
infect
number
insect
order
includ
diptera
lepidoptera
typic
amino
acid
size
boman
cecropin
cecropinlik
peptid
highli
conserv
predominantli
alpha
helic
group
peptid
broad
spectrum
antibacteri
antifung
activ
bulet
stocklin
recent
studi
reveal
matur
form
induc
cecropinlik
peptid
found
salivari
gland
femal
mosquito
aedesaegypti
substanti
antivir
activ
dengu
viru
luplertlop
et
al
viru
util
aaegypti
vector
transmiss
human
induc
innat
immun
respons
character
express
cecropinlik
peptid
produc
upregul
gene
peptid
subsequ
cleav
cmv
dsdna
modest
direct
antivir
effect
daher
et
al
ssrna
direct
effect
virion
block
viral
interact
block
host
pkc
signal
affect
revers
transcript
integr
increas
secret
cc
chemokin
wang
et
al
immatur
form
matur
activ
form
interestingli
immatur
mk
form
cecropinlik
peptid
activ
four
strain
dengu
viru
test
matur
gk
cleav
form
author
also
establish
gk
mk
form
peptid
activ
chikungunya
viru
pathogen
also
transmit
aegypti
mosquito
caus
fever
sever
long
last
joint
pain
anoth
studi
reveal
scorpin
hybrid
peptid
structur
similar
cecropin
defensin
deriv
venom
scorpion
pandinu
imper
also
exhibit
antivir
activ
dengu
viru
inhibit
replic
viru
carballarlejarazu
et
al
cecropin
report
inhibit
hiv
product
infect
tcell
fibroblast
dosedepend
manner
waching
et
al
mechan
respons
inhibit
found
reduc
viral
gene
express
synthesi
viral
product
indic
cecropin
antivir
role
beyond
direct
interact
hiv
virion
cecropin
also
shown
antivir
activ
earli
late
point
viral
infect
replic
cycl
exampl
cecropin
cecropin
shown
antivir
activ
sever
stage
infect
porcin
reproduct
respiratori
syndrom
viru
prrsv
infect
substanti
financi
impact
pig
industri
cecropin
peptid
initi
thought
produc
porcin
intestin
lee
et
al
later
reveal
produc
nematod
ascarissuum
surviv
porcin
gut
andersson
et
al
peptid
shown
block
attach
replic
viru
kidney
alveolar
macrophag
cell
line
also
reduc
number
infecti
viral
particl
produc
infect
vitro
guo
et
al
peptid
also
shown
immunomodulatori
properti
prevent
onset
prrsvinduc
apoptosi
similarli
cecropin
recent
shown
inhibit
prrsv
attach
replic
also
attenu
apoptosi
induc
viru
liu
et
al
broad
spectrum
antivir
activ
cecropin
evidenc
studi
demonstr
cecropin
could
inhibit
replic
junin
viru
caus
argentin
hemorrhag
fever
albiol
matan
castilla
peptid
inhibit
junin
virusrel
protein
product
host
cell
author
suggest
antivir
effect
predominantli
limit
later
stage
viru
replic
cycl
sinc
peptid
appear
alter
viral
infect
interestingli
studi
also
demonstr
cecropin
exhibit
inhibitori
activ
herp
simplex
viru
type
suggest
antivir
activ
exhibit
peptid
pathogen
specif
note
contain
dna
genom
contrast
junin
prrsv
dengu
rna
virus
thu
activ
cecropin
dna
virus
remain
understood
substanti
number
host
defenc
peptid
identifi
amphibian
skin
dermaseptin
superfamili
host
defenc
peptid
cation
charg
due
abund
lysin
residu
tend
amino
acid
size
amich
et
al
found
sever
speci
frog
includ
hylida
tree
frog
ranida
true
frog
nicola
el
amri
dermaseptin
demonstr
antimicrobi
activ
wide
rang
bacteri
pathogen
involv
human
diseas
includ
pseudomona
salmonella
staphylococcu
escherichia
enterobact
speci
interestingli
peptid
dermaseptin
peptid
isol
frog
genu
phyllomedusa
shown
immunomodulatori
activ
via
abil
stimul
product
reactiv
oxygen
speci
myeloperoxidas
primari
human
neutrophil
ammar
et
al
dermaseptin
also
tout
potenti
therapeut
molecul
treatment
cancer
recent
studi
demonstr
antitumor
angiostat
activ
rang
tumour
cell
type
like
due
induct
necrosi
van
zoggel
et
al
term
antivir
activ
dermaseptin
shown
highli
effect
broad
rang
viral
pathogen
activ
affect
sever
step
infect
replic
process
initi
identifi
antivir
activ
two
virus
known
infect
ectotherm
anim
frog
viru
famili
iridovirida
channel
catfish
viru
member
herpesvirida
famili
chinchar
et
al
studi
provid
indic
dermaseptin
peptid
possess
antivir
activ
subsequ
studi
extend
examin
activ
human
viral
pathogen
dermaseptin
shown
direct
vari
antivir
activ
herp
simplex
vitro
belaid
et
al
studi
identifi
dermaseptin
potent
antivir
activ
earli
stage
viral
infect
process
experi
suggest
exert
effect
expos
viru
prior
infect
viral
attach
later
studi
evalu
activ
dermaseptin
deriv
herp
simplex
viru
demonstr
antivir
activ
parent
peptid
could
increas
alter
origin
sequenc
savoia
et
al
interestingli
studi
also
show
deriv
also
exhibit
activ
papillomaviru
vitro
low
cytotox
toward
host
cell
recent
studi
bergaoui
et
al
also
demonstr
dermaseptin
synthet
deriv
exhibit
activ
herp
simplex
reduc
cytotox
although
vivo
efficaci
remain
determin
bergaoui
et
al
studi
reveal
possibl
role
dermaseptin
treatment
infect
dermaseptin
shown
partial
inhibit
hiv
viru
infect
tcell
although
cytotox
observ
higher
concentr
vancompernol
et
al
anoth
studi
lorin
et
al
identifi
dermaseptin
potenti
inhibitori
activ
inhibit
viral
infect
human
primari
tlymphocyt
lorin
et
al
author
attribut
activ
direct
disrupt
virion
parent
peptid
elicit
cytotox
higher
concentr
abl
reduc
host
cell
cytotox
reduc
posit
charg
nativ
peptid
amino
acid
delet
substitut
notabl
modifi
peptid
also
abl
reduc
bind
endometri
cell
togeth
inhibit
captur
transmiss
viru
dendrit
cell
tcell
dermaseptin
also
identifi
weak
activ
mutant
peptid
three
lysin
residu
replac
arginin
exhibit
potent
inhibitori
activ
although
mechan
underli
observ
remain
unclear
magainin
cation
host
defenc
peptid
origin
identifi
skin
granular
secret
xenopuslaevi
african
claw
frog
zasloff
giovannini
et
al
also
identifi
induc
peptid
speci
xenopu
genu
x
boreali
x
clivii
x
muelleri
x
petersii
x
amieti
x
andrei
conlon
et
al
peptid
amino
acid
length
nativ
peptid
togeth
synthet
deriv
demonstr
broad
antimicrobi
activ
rang
bacteri
pathogen
zairi
et
al
chen
et
al
howev
limit
amount
inform
activ
magainin
viral
pathogen
one
studi
assess
activ
number
synthet
magainin
deriv
herp
viru
establish
sever
peptid
deriv
capac
reduc
viral
plaqu
format
vitro
assay
egal
et
al
evid
antivir
activ
magainin
also
reveal
studi
chinchar
et
al
show
magainin
ii
magainin
abl
reduc
infect
channel
catfish
viru
ccv
chinchar
et
al
howev
magainin
exhibit
less
activ
frog
viru
indic
activ
like
viru
specif
melittin
alpha
helic
peptid
amino
acid
length
initi
identifi
bee
venom
habermann
jentsch
later
character
amphipath
peptid
broad
rang
antimicrobi
activ
terwillig
eisenberg
wade
et
al
nativ
melittin
peptid
synthet
analogu
investig
number
studi
potenti
novel
antimicrobi
therapeut
wellcharacter
antivir
activ
number
pathogen
particular
interest
one
first
studi
assess
antivir
activ
melittin
publish
waching
et
al
identifi
melittin
six
deriv
reduc
replic
host
cell
waching
et
al
subsequ
studi
reveal
mechan
underli
inhibit
melittin
capabl
specif
reduc
hivassoci
gene
express
host
cell
affect
overal
gene
express
profil
waching
et
al
suggest
import
immunomodulatori
role
peptid
rather
direct
antivir
activ
potenti
contribut
treatment
hiv
infect
sever
studi
also
character
influenc
melittin
synthet
deriv
upon
establish
progress
herp
simplex
viru
infect
baghian
et
al
synthes
number
deriv
base
upon
origin
melittin
structur
assess
antivir
activ
viru
one
peptid
call
hecat
alter
amino
sequenc
chang
distribut
charg
residu
within
peptid
without
alter
overal
amphipath
structur
baghian
et
al
author
determin
hecat
prevent
plaqu
format
prevent
viru
spread
vitro
model
synthet
melittin
analogu
unabl
suggest
sequenc
play
import
role
antivir
activ
peptid
later
studi
screen
number
known
chdp
establish
mani
peptid
screen
includ
magainin
cecropin
cathelicidin
display
activ
virus
yasin
et
al
howev
melittin
substanti
activ
although
mechan
underli
observ
fulli
describ
recent
demonstr
nativ
melittin
peptid
show
antivir
activ
toward
junin
viru
albiol
matan
castilla
synthet
melittin
analogu
show
activ
toward
tobacco
mosaic
viru
marco
et
al
interestingli
recent
studi
falco
et
al
use
melittinload
liposom
specif
target
fish
viral
hemorrhag
septicemia
rhabdoviru
vhsv
falco
et
al
author
coat
immunoliposom
antibodi
target
surfac
g
glycoprotein
vhsv
show
reduct
infect
greater
approach
provid
excit
avenu
target
deliveri
antivir
host
defenc
peptid
whilst
minim
cytotox
damag
host
cell
tachyplesin
amino
acid
cation
peptid
origin
identifi
hemocyt
tachypleustridentatu
horsesho
crab
demonstr
broad
spectrum
antimicrobi
activ
nakamura
et
al
polyphemusin
amino
acid
peptid
identifi
hemocyt
american
horsesho
crab
limulu
polyphemu
peptid
thought
play
key
role
innat
immun
system
crab
shown
potent
lp
bind
neutral
activ
nakamura
et
al
power
et
al
antivir
activ
tachyplesin
hiv
investig
morimoto
et
al
show
peptid
could
reduc
virusmedi
cytopath
effect
vitro
model
morimoto
et
al
peptid
also
reduc
infect
viru
effect
shown
independ
revers
transcriptas
activ
hiv
interestingli
subsequ
studi
nakashima
et
al
murakami
et
al
xu
et
al
character
activ
tyr
ly
polyphemusin
ii
synthet
analogu
hiv
determin
antivir
activ
due
abil
peptid
bind
xu
et
al
murakami
et
al
nakashima
et
al
chemokin
receptor
use
tcell
tropic
strain
hiv
infect
host
cell
thu
host
cell
mediat
mechan
action
peptid
hiv
contrast
direct
antivir
activ
exhibit
chdp
tachplesin
peptid
also
demonstr
activ
virus
affect
human
shown
tachyplesin
peptid
abl
inactiv
vesicular
stomat
viru
vsv
also
known
vesicular
stomat
indiana
viru
zoonot
member
famili
rhabdovirida
infect
cattl
caus
diseas
human
murakami
et
al
studi
also
identifi
influenza
also
moder
suscept
although
suscept
antivir
activ
peptid
howev
subsequ
studi
examin
antivir
activ
tachyplesin
use
vitro
cytotox
model
suggest
peptid
offer
moder
degre
protect
viru
strain
yasin
et
al
collect
experiment
studi
present
highlight
crucial
role
chdp
play
innat
immun
respons
across
wide
varieti
cell
type
speci
peptid
possess
power
antivir
activ
modul
cellular
immun
respons
provid
key
defenc
mechan
infect
patholog
associ
myriad
virus
begin
understand
underli
mechan
cathelicidin
defensin
chdp
mediat
antivir
effect
research
activ
peptid
still
rel
infanc
clear
howev
chdp
huge
therapeut
potenti
exogen
peptid
develop
power
synthet
analogu
direct
toward
specif
viral
pathogen
disclosur
fund
interest
fh
support
edinburgh
napier
univers
anniversari
research
studentship
pgb
cs
receipt
project
grant
award
chief
scientist
offic
scotland
